日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real world clinical outcomes of treatment of cannabis-induced psychosis and prevalence of cannabis-related primary psychosis: a retrospective study

大麻诱发精神病治疗的真实世界临床结果及大麻相关原发性精神病的患病率：一项回顾性研究

期刊:BMC Psychiatry
影响因子:3.6
doi:10.1186/s12888-024-06075-6
Chuenchom, Onrumpha; Suansanae, Thanarat; Lukanapichonchut, Lumsum; Suwanmajo, Somporn; Suthisisang, Chuthamanee
发表日期：2024
文献求助 收藏

Implementing pain, agitation, delirium, and sleep deprivation protocol in critically ill patients: A pilot study on pharmacological interventions

在危重病人中实施疼痛、躁动、谵妄和睡眠剥夺方案：一项关于药物干预的试点研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13739
Luetrakool, Punchika; Taesotikul, Suthinee; Susantitapong, Kanyarat; Suthisisang, Chuthamanee; Morakul, Sunthiti; Sutherasan, Yuda; Tangsujaritvijit, Viratch; Dilokpattanamongkol, Pitchaya
发表日期：2024
文献求助 收藏

Pharmacokinetics and pharmacodynamics studies of a loading dose of cisatracurium in critically ill patients with respiratory failure

对呼吸衰竭危重患者给予顺式阿曲库铵负荷剂量进行药代动力学和药效学研究

期刊:BMC Anesthesiology
影响因子:2.6
doi:10.1186/s12871-022-01571-2
Panusitthikorn, Panadda; Suthisisang, Chuthamanee; Tangsujaritvijit, Viratch; Nosoongnoen, Wichit; Dilokpattanamongkol, Pitchaya
发表日期：2022
文献求助 收藏

Strategies for the use of Ginkgo biloba extract, EGb 761(®) , in the treatment and management of mild cognitive impairment in Asia: Expert consensus

亚洲地区应用银杏叶提取物EGb 761®治疗和管理轻度认知障碍的策略：专家共识

期刊:CNS Neuroscience & Therapeutics
影响因子:5
doi:10.1111/cns.13536
Kandiah, Nagaendran; Chan, Yee Fai; Chen, Christopher; Dasig, Darwin; Dominguez, Jacqueline; Han, Seol-Heui; Jia, Jianping; Kim, SangYun; Limpawattana, Panita; Ng, Li-Ling; Nguyen, Dinh Toan; Ong, Paulus Anam; Raya-Ampil, Encarnita; Saedon, Nor'izzati; Senanarong, Vorapun; Setiati, Siti; Singh, Harjot; Suthisisang, Chuthamanee; Trang, Tong Mai; Turana, Yuda; Venketasubramanian, Narayanaswamy; Yong, Fee Mann; Youn, Yong Chul; Ihl, Ralf
神经科学
发表日期：2021
文献求助 收藏

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761(®)

治疗伴或不伴脑血管疾病的痴呆症和轻度认知障碍：关于使用银杏叶提取物 EGb 761(®) 的专家共识

期刊:CNS Neuroscience & Therapeutics
影响因子:5
doi:10.1111/cns.13095
Kandiah, Nagaendran; Ong, Paulus Anam; Yuda, Turana; Ng, Li-Ling; Mamun, Kaysar; Merchant, Reshma Aziz; Chen, Christopher; Dominguez, Jacqueline; Marasigan, Simeon; Ampil, Encarnita; Nguyen, Van Thong; Yusoff, Suraya; Chan, Yee Fai; Yong, Fee Mann; Krairit, Orapitchaya; Suthisisang, Chuthamanee; Senanarong, Vorapun; Ji, Yong; Thukral, Ramesh; Ihl, Ralf
神经科学
发表日期：2019
文献求助 收藏

Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist-physician collaboration in the outpatient department

精神分裂症患者停用抗胆碱能药物及其对认知功能的影响：门诊药师与医生的合作

期刊:Integrated Pharmacy Research and Practice
影响因子:2.1
doi:10.2147/IPRP.S176653
Sathienluckana, Thanompong; Unaharassamee, Weerapon; Suthisisang, Chuthamanee; Suanchang, Orabhorn; Suansanae, Thanarat
精神分裂症
神经科学
发表日期：2018
文献求助 收藏

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

亚太地区中重度阿尔茨海默病患者使用多奈哌齐23毫克的临床建议

期刊:Dementia and Geriatric Cognitive Disorders Extra
影响因子:1.6
doi:10.1159/000448214
Sabbagh, Marwan; Han, SeolHeui; Kim, SangYun; Na, Hae-Ri; Lee, Jae-Hong; Kandiah, Nagaendran; Phanthumchinda, Kammant; Suthisisang, Chuthamanee; Senanarong, Vorapun; Pai, Ming-Chyi; Narilastri, Diatri; Sowani, Ajit M; Ampil, Encarnita; Dash, Amitabh
阿尔茨海默症
发表日期：2016
文献求助 收藏